HLA-DR15 is associated with lower age at onset in multiple sclerosis

T Masterman1, A Ligers, T Olsson

  • 1Department of Neurology, Karolinska Institutet at Huddinge University Hospital, Sweden.

Annals of Neurology
|August 12, 2000
PubMed

Insights

Human Leukocyte Antigen (HLA) genes DR15 and DR17 are associated with multiple sclerosis (MS) susceptibility. However, HLA-DRB1 alleles do not impact MS disease course or severity, though DR15 carriers may develop MS earlier.

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Human Genetics

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with a complex etiology.
  • Human Leukocyte Antigen (HLA) genes are known to influence MS susceptibility, but previous studies had small sample sizes.
  • Consistent patterns regarding HLA gene impact on MS clinical course and severity have been lacking.

Purpose of the Study:

  • To investigate the impact of HLA-DRB1 alleles on the clinical course and disease severity in MS.
  • To compare the frequencies of the DR15 susceptibility allele in various clinicodemographic subgroups of MS patients.
  • To identify novel HLA associations with MS susceptibility using the largest dataset to date.

Main Methods:

  • Genotyping of HLA class II alleles in 948 MS patients.
  • Cataloguing of clinical and demographic data for all participants.
  • Statistical analysis to correlate HLA genotypes with MS susceptibility, clinical course, and disease severity.

Main Results:

  • HLA-DR17, in addition to DR15, is positively associated with MS susceptibility.
  • No investigated HLA-DRB1 alleles were found to influence the clinical course or outcome of MS.
  • DR15 carriers were found to develop MS at an earlier age compared to non-carriers.
  • DR15 positivity rates varied across diagnostic categories, potentially reflecting phenocopy contamination.

Conclusions:

  • HLA-DR15 and DR17 are confirmed as susceptibility alleles for MS.
  • HLA-DRB1 alleles do not appear to be determinants of MS disease progression or severity.
  • Early-onset MS is associated with DR15 carriage.
  • Further research is needed to understand the role of HLA in MS pathogenesis and to refine diagnostic criteria.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...